Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Somerset Therapeutics, LLC
- Package NDC
- 70069-753-25
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25)
- Initial Posting
- Feb 20, 2018
Reason
Other